Stock DNA
Commercial Services & Supplies
INR 12 Cr ()
10.00
20
0.00%
0.00
0.00%
1.73
Total Returns (Price + Dividend) 
Tradewell Hold for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News
Announcements 
Announcement under Regulation 30 (LODR)-Change in Registered Office Address
03-Jun-2026 | Source : BSEWe wish to inform you that the Board of Directors at its meeting held on 03 June 2026 has approved the shifting of the registered office of the company within the local limits of the city
Announcement under Regulation 30 (LODR)-Newspaper Publication
31-May-2026 | Source : BSEPlease find enclosed herewith Newspaper Advertisement regarding Audited Financial results for the quarter & year ended March 31 2026
AUDITED STANDALONE FINANCIAL RESULTS OF THE COMPANY FOR THE FOURTH QUARTER AND YEAR ENDED 31ST MARCH 2026 AS PER THE REGULATIONS 33 OF SEBI (LISTING OBLIGATIONS & DISCLOSURE REQUIREMENTS) REGULATIONS 2015
30-May-2026 | Source : BSEPlease find attached herewith Audited Financial results of the Company for the year ended March 31 2026
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Kamal Manchanda (48.02%)
Rashmi Gupta (9.5%)
21.45%
Quarterly Results Snapshot (Standalone) - Mar'26 - YoY
YoY Growth in quarter ended Mar 2026 is 168.42% vs -99.27% in Mar 2025
YoY Growth in quarter ended Mar 2026 is -175.00% vs -68.70% in Mar 2025
Annual Results Snapshot (Standalone) - Mar'26
YoY Growth in year ended Mar 2026 is -81.09% vs -69.73% in Mar 2025
YoY Growth in year ended Mar 2026 is 434.21% vs -115.38% in Mar 2025